Tirzepatide vs Semaglutide
Which is more effective for weight loss, Tirzepatide (Mounjaro / Zepbound) or Semaglutide (Ozempic / Wegovy)? Side-by-side on dose, mechanism, side effects, FDA status.
Tirzepatide is the prescription weight-loss drug sold as Mounjaro (diabetes) or Zepbound (weight loss). It hits two appetite-control receptors at once. Most users lose 15-20% of body weight over several months. One injection per week.
Semaglutide is the first wave of modern weight-loss drugs — sold as Ozempic and Wegovy. Single-receptor version of Tirzepatide. Slightly less effective and slightly rougher side effects, but well-studied and widely available.
Which one should you pick?
Pick Tirzepatide if users who couldn't tolerate semaglutide or metabolic-syndrome adults under provider guidance.
Pick Semaglutide if beginners to glp-class peptides or users with insurance coverage on wegovy / ozempic.